Pre-exposure Prophylaxis (PrEP) Rapid Access
- Conditions
- Opioid Use DisorderDrug UsePre-exposure Prophylaxis (PrEP)
- Registration Number
- NCT05528562
- Lead Sponsor
- Boston Medical Center
- Brief Summary
The goal of phase 1 is to determine the feasibility and acceptability of an intervention ('Rapid PrEP Access') providing people who use drugs (PWUD) one-time access to HIV self-testing at the Victory Program.
Aim 1: To offer HIV self-testing to PWUD in the community through a study called 'Rapid PrEP Access'. The study will be carried out at the Victory Program.
Aim 2: To determine the feasibility and acceptability of 'Rapid PrEP Access' at the Victory Program.
- Detailed Description
For phase 1 of the study, participants will be recruited for a one-time baseline interview and HIV self-testing. A questionnaire will also be administered to assess their interest in the HIV prevention pill (PrEP= pre-exposure prophylaxis), but PrEP will not be offered. Study duration for each participant is one day; participants will not be followed over time.
After the prescreener and consent forms are completed, the Research Assistant (RA) will offer the participant an opportunity to administer an HIV self-test. The participant will be provided the test for unboxing and retrieving the user instructions.
All testing will be performed and interpreted by participants. The RA can provide assistance with reading the instruction on how to obtain a proper sample. Alternatively, the RA will direct them to information in the package insert which includes support offered by the OraQuick® Support Center.
After completing the HIVST, the RA will complete the baseline questionnaire with each participant while waiting for the participants' HIVST results. After the baseline questionnaire is complete, the RA will conduct satisfaction surveys to assess acceptability of the intervention and interest of PrEP initiation using REDCap.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- English speaking
- Opioid use that was not prescribed by a health professional in the past 6 months
- Pregnant women
- Persons with previous HIV diagnosis
- Individuals currently taking PrEP
- Individuals who express desire to harm themselves or others
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of participants enrolled 12 months Feasibility will be assessed by the number of participants enrolled
Acceptability of PrEP rapid Access Through study completion, an average of 1 year Participants will rate PrEP Rapid Access' acceptability using an investigator-developed scale ranging from 1 to 5 where 1= not acceptable and 5 is very acceptable.
- Secondary Outcome Measures
Name Time Method Number of participants interested in initiating PrEP Through study completion, an average of 1 year This information will be obtained from information recorded on the day of recruitment from the survey data.
Number of participants who perform HIV self-test Through study completion, an average of 1 year This information will be obtained from information recorded on the day of recruitment for the study.
Trial Locations
- Locations (1)
Victory Program
🇺🇸Boston, Massachusetts, United States
Victory Program🇺🇸Boston, Massachusetts, United States